Torthaí cuardaigh - Douglas Galasko
- 1 - 20 toradh as 193 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Lewy Body Disorders de réir Douglas Galasko
Foilsithe / Cruthaithe 2017Revisão -
2
Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease de réir Douglas Galasko, Thomas J. Montine
Foilsithe / Cruthaithe 2010Revisão -
3
Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems de réir Douglas Galasko, Todd E. Golde
Foilsithe / Cruthaithe 2013Revisão -
4
Distinctive patterns of DNA methylation associated with Parkinson disease de réir Eliezer Masliah, Wilmar Dumaop, Douglas Galasko, Paula Desplats
Foilsithe / Cruthaithe 2013Artigo -
5
Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimerʼs Disease de réir William Samuel, Douglas Galasko, Eliezer Masliah, Lawrence A. Hansen
Foilsithe / Cruthaithe 1996Artigo -
6
Stimulated platelets release amyloid β-protein precursor de réir Gregory M. Cole, Douglas Galasko, Igor Shapiro, Tsunao Saitoh
Foilsithe / Cruthaithe 1990Artigo -
7
Effect of Knowledge of APOE Genotype on Subjective and Objective Memory Performance in Healthy Older Adults de réir Tara T. Lineweaver, Mark W. Bondi, Douglas Galasko, David P. Salmon
Foilsithe / Cruthaithe 2013Artigo -
8
-
9
Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults de réir Zvinka Z. Zlatar, Martha C. Muniz, Douglas Galasko, David P. Salmon
Foilsithe / Cruthaithe 2016Artigo -
10
Subjective Cognitive Complaints Contribute to Misdiagnosis of Mild Cognitive Impairment de réir Emily C. Edmonds, Lisa Delano‐Wood, Douglas Galasko, David P. Salmon, Mark W. Bondi
Foilsithe / Cruthaithe 2014Artigo -
11
Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer’s Disease de réir Emily C. Edmonds, Lisa Delano‐Wood, Douglas Galasko, David P. Salmon, Mark W. Bondi
Foilsithe / Cruthaithe 2015Artigo -
12
Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone de réir Erin E. Sundermann, Matthew S. Panizzon, Xu Chen, Murray Andrews, Douglas Galasko, Sarah J. Banks
Foilsithe / Cruthaithe 2020Artigo -
13
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease de réir Marwan N. Sabbagh, Albert Agro, J. Simon Bell, Paul Aisen, Edward E. Schweizer, Douglas Galasko
Foilsithe / Cruthaithe 2010Artigo -
14
-
15
Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers de réir Thomas J. Montine, Elaine R. Peskind, Joseph F. Quinn, Angela Wilson, Kathleen S. Montine, Douglas Galasko
Foilsithe / Cruthaithe 2010Artigo -
16
Effectiveness and utilization of a cognitive screening program for primary geriatric care de réir David P. Salmon, Anna Malkina, Melanie L. Johnson, Christina Gigliotti, Emily A. Little, Douglas Galasko
Foilsithe / Cruthaithe 2025Artigo -
17
Early Visuospatial Deficits Predict the Occurrence of Visual Hallucinations in Autopsy-Confirmed Dementia With Lewy Bodies de réir Joanne M. Hamilton, Kelly M. Landy, David P. Salmon, Lawrence A. Hansen, Eliezer Masliah, Douglas Galasko
Foilsithe / Cruthaithe 2011Artigo -
18
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease de réir Aaron H. Burstein, Imogene Grimes, Douglas Galasko, Paul Aisen, Marwan N. Sabbagh, Adnan M.M. Mjalli
Foilsithe / Cruthaithe 2014Artigo -
19
Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies de réir Denis S. Smirnov, Douglas Galasko, Steven D. Edland, J. Vincent Filoteo, Lawrence A. Hansen, David P. Salmon
Foilsithe / Cruthaithe 2020Artigo -
20
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Disease
Pathology
Internal medicine
Biology
Dementia
Alzheimer's disease
Psychology
Biochemistry
Gene
Psychiatry
Neuroscience
Biomarker
Genetics
Cerebrospinal fluid
Cognition
Parkinson's disease
Oncology
Chemistry
Bioinformatics
Cognitive decline
Cognitive impairment
Cohort
Genotype
Neurodegeneration
Dementia with Lewy bodies
Gastroenterology
Single-nucleotide polymorphism
Lewy body
Neuropsychology